An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online in The New England Journal of Medicine.
The ongoing...
Experimental COVID-19 Vaccine Safe, Generates Immune Response
Eurasia Review
0 shares
1 views
You might like
Related news coverage
First human trial of Oxford Covid-19 vaccine shows promise
WorldNews
London - An experimental coronavirus vaccine being developed by AstraZeneca and Oxford university was safe and produced an immune..
-
Now China COVID vaccine shows promising result
Mid-Day
-
Oxford vaccine triggers immune response, safe
Mid-Day
-
Support grows for deliberately exposing vaccine trial subjects to COVID-19, with Oxford team leading the way
National Post
-
Chinese phase 2 trial finds COVID-19 vaccine is safe and induces an immune response
Science Daily
Advertisement
More coverage
Moderna shares soar 18% after early coronavirus vaccine trial produces antibodies in all patients (MRNA)
Business Insider
· *Moderna stock surged as much as 18% on Wednesday after the company announced an early coronavirus vaccine trial produced..